Ranbaxy shares up on FDA approval for generic Aricept
This article was originally published in Scrip
Executive Summary
Shares of Ranbaxy Laboratories made strong gains on Indian bourses on news that the company has received final US FDA approval to launch a generic version of Eisai's Alzheimer's drug, Aricept (donepezil hydrochloride).